CD11c+ Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes
Authors:
Open Access
- 31 January 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 99
Abstract
Type 1 diabetes (T1D) is a T cell mediated autoimmune disease that affects more than 19 million people with incidence increasing rapidly worldwide. For T cells to effectively drive T1D, they must first traffic to the islets and extravasate through the islet vasculature. Understanding the cues that lead to T cell entry into inflamed islets is important because diagnosed T1D patients already have established immune infiltration of their islets. Here we show that CD11c+ cells are a key mediator of T cell trafficking to infiltrated islets in non-obese diabetic (NOD) mice. Using intravital 2-photon islet imaging we show that T cell extravasation into the islets is an extended process, with T cells arresting in the islet vasculature in close proximity to perivascular CD11c+ cells. Antigen is not required for T cell trafficking to infiltrated islets, but T cell chemokine receptor signaling is necessary. Using RNAseq, we show that islet CD11c+ cells express over 20 different chemokines that bind chemokine receptors expressed on islet T cells. One highly expressed chemokine-receptor pair is CXCL16-CXCR6. However, NOD. CXCR6−/− mice progressed normally to T1D and CXCR6 deficient T cells trafficked normally to the islets. Even with CXCR3 and CXCR6 dual deficiency, T cells trafficked to infiltrated islets. These data reinforce that chemokine receptor signaling is highly redundant for T cell trafficking to inflamed islets. Importantly, depletion of CD11c+ cells strongly inhibited T cell trafficking to infiltrated islets of NOD mice. We suggest that targeted depletion of CD11c+ cells associated with the islet vasculature may yield a therapeutic target to inhibit T cell trafficking to inflamed islets to prevent progression of T1D.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH 1R01DK111733-01)
- National Institute of Allergy and Infectious Diseases
- Juvenile Diabetes Research Foundation United States of America (#2-2012-197)
This publication has 82 references indexed in Scilit:
- Antigen presentation events in autoimmune diabetesCurrent Opinion in Immunology, 2012
- Intravital imaging of CTLs killing islet cells in diabetic miceJournal of Clinical Investigation, 2012
- Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular responseProceedings of the National Academy of Sciences, 2011
- Cellular and molecular events in the localization of diabetogenic T cells to islets of LangerhansProceedings of the National Academy of Sciences, 2011
- Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sitesJournal of Immunological Methods, 2010
- T Cell Islet Accumulation in Type 1 Diabetes Is a Tightly Regulated, Cell-Autonomous EventImmunity, 2009
- Mouse models for Type 1 DiabetesDrug Discovery Today: Disease Models, 2009
- Lymphocyte Crawling and Transendothelial Migration Require Chemokine Triggering of High-Affinity LFA-1 IntegrinImmunity, 2009
- Getting to the site of inflammation: the leukocyte adhesion cascade updatedNature Reviews Immunology, 2007
- Shear flow–dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigmBlood, 2006